Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Langer-Gould

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Neurology|January 23, 2024
Disparities in Maternal and Infant Outcomes: What's a Neurologist to Do?Annette Langer-Gould, Irogue I Igbinosa
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2018
Vitamin D deficiency is an etiological factor for MS - NoAnnette Langer-Gould, Robyn M Lucas
Clinical Immunology (Orlando, Fla.)|February 26, 2013
Effects of pregnancy and breastfeeding on the multiple sclerosis disease courseAnnette Langer-Gould, Brandon E Beaber
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|June 4, 2009
Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis populationCraig H Smith, Emmanuelle Waubant, Annette Langer-Gould
Neurology|January 2, 2024
Rituximab for Multiple Sclerosis: Hiding in Plain SightAnnette Langer-Gould, Elias S Sotirchos, Dennis Bourdette
Multiple Sclerosis and Related Disorders|April 5, 2024
Traumatic brain injury, race, ethnicity and cognition in newly diagnosed persons with multiple sclerosisJemima Akinsanya, Jessica B Smith, Annette Langer-Gould
Epidemiology (Cambridge, Mass.)|February 6, 2019
Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic EvaluationsPeter Alping, Fredrik Piehl, Annette Langer-Gould, et al.
Neurology|December 15, 2004
Strategies for managing the side effects of treatments for multiple sclerosisAnnette Langer-Gould, Harold H Moses, T Jock Murray
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 19, 2025
Migraines, the multiple sclerosis prodrome, and multiple sclerosis susceptibilityVinicius A Schoeps, Jessica B Smith, Annette Langer-Gould
Annals of Clinical and Translational Neurology|March 30, 2021
Multiple sclerosis, rituximab, and COVID-19Annette Langer-Gould, Jessica B Smith, Bonnie H Li, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Neurology|January 23, 2024
Disparities in Maternal and Infant Outcomes: What's a Neurologist to Do?Annette Langer-Gould, Irogue I Igbinosa
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2018
Vitamin D deficiency is an etiological factor for MS - NoAnnette Langer-Gould, Robyn M Lucas
Clinical Immunology (Orlando, Fla.)|February 26, 2013
Effects of pregnancy and breastfeeding on the multiple sclerosis disease courseAnnette Langer-Gould, Brandon E Beaber
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|June 4, 2009
Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis populationCraig H Smith, Emmanuelle Waubant, Annette Langer-Gould
Neurology|January 2, 2024
Rituximab for Multiple Sclerosis: Hiding in Plain SightAnnette Langer-Gould, Elias S Sotirchos, Dennis Bourdette
Multiple Sclerosis and Related Disorders|April 5, 2024
Traumatic brain injury, race, ethnicity and cognition in newly diagnosed persons with multiple sclerosisJemima Akinsanya, Jessica B Smith, Annette Langer-Gould
Epidemiology (Cambridge, Mass.)|February 6, 2019
Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic EvaluationsPeter Alping, Fredrik Piehl, Annette Langer-Gould, et al.
Neurology|December 15, 2004
Strategies for managing the side effects of treatments for multiple sclerosisAnnette Langer-Gould, Harold H Moses, T Jock Murray
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 19, 2025
Migraines, the multiple sclerosis prodrome, and multiple sclerosis susceptibilityVinicius A Schoeps, Jessica B Smith, Annette Langer-Gould
Annals of Clinical and Translational Neurology|March 30, 2021
Multiple sclerosis, rituximab, and COVID-19Annette Langer-Gould, Jessica B Smith, Bonnie H Li, et al.
Pageof 9